RxDoctor Payments Data

John Welter

Pediatric Pulmonology · Hawthorne, NYNPI 1235139684

Payments from drug & device makers

What this record shows

Vertex accounts for 90.3% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2019 at $1,794 and has fallen 91.1% since, to $160 in 2025.

$2,166in general payments, 2019–2025

Across 23 payments — averaging $94.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Vertex$2K
  • Viatris Specialty LLC$131
  • GSK$30
  • Alcresta Therapeutics, Inc.$30
  • AbbVie$20
$783,078in research payments, 2019–2025

Across 60 payments — averaging $13,051 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Vertex$757K
  • AbbVie$22K
  • Boehringer Ingelheim International GmbH$4K
  • Vivus LLC$616

What the payments were for

  • Travel & lodging$1,11652%
  • Food & beverage$1,05048%

General payments by program year

19
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Vertex19$1,955
Viatris Specialty LLC1$131
GSK1$30
Alcresta Therapeutics, Inc.1$30
AbbVie1$20

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,166 in reported general payments places this provider in the 80th percentile of 102 pediatric pulmonology providers in New York.

See all pediatric pulmonology providers in New York

Other pediatric pulmonology in Hawthorne

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →